Barbara Scappini

1.2k total citations
42 papers, 578 citations indexed

About

Barbara Scappini is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Barbara Scappini has authored 42 papers receiving a total of 578 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 17 papers in Genetics and 8 papers in Oncology. Recurrent topics in Barbara Scappini's work include Acute Myeloid Leukemia Research (18 papers), Chronic Myeloid Leukemia Treatments (17 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Barbara Scappini is often cited by papers focused on Acute Myeloid Leukemia Research (18 papers), Chronic Myeloid Leukemia Treatments (17 papers) and Chronic Lymphocytic Leukemia Research (11 papers). Barbara Scappini collaborates with scholars based in Italy, United States and Czechia. Barbara Scappini's co-authors include Francesco Onida, Hagop M. Kantarjian, Srđan Verstovšek, Miloslav Beran, Michael J. Keating, Antonella Gozzini, Clara Ricci, Vladimír Divoký, Greg Ball and Alberto Grossi and has published in prestigious journals such as Blood, Cancer and Oncotarget.

In The Last Decade

Barbara Scappini

38 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Scappini Italy 15 395 242 187 119 110 42 578
Rafal Falinski United States 5 386 1.0× 215 0.9× 206 1.1× 128 1.1× 56 0.5× 8 505
Roberta Rostagno Italy 5 284 0.7× 227 0.9× 121 0.6× 142 1.2× 93 0.8× 6 464
Christian Scharenberg Sweden 6 239 0.6× 175 0.7× 191 1.0× 61 0.5× 215 2.0× 9 487
Cristina Panuzzo Italy 15 316 0.8× 171 0.7× 401 2.1× 49 0.4× 122 1.1× 49 644
Emanuela Messa Italy 11 456 1.2× 275 1.1× 277 1.5× 32 0.3× 60 0.5× 35 629
Ilaria Defilippi Italy 9 312 0.8× 197 0.8× 215 1.1× 29 0.2× 56 0.5× 21 501
Giovanna Rege Cambrin Italy 13 518 1.3× 405 1.7× 110 0.6× 191 1.6× 58 0.5× 28 609
Amity Frede Australia 8 396 1.0× 323 1.3× 58 0.3× 174 1.5× 123 1.1× 13 472
Victoria Raggueneau France 6 196 0.5× 114 0.5× 143 0.8× 50 0.4× 71 0.6× 9 348
Florian Perner Germany 10 238 0.6× 124 0.5× 293 1.6× 38 0.3× 64 0.6× 26 471

Countries citing papers authored by Barbara Scappini

Since Specialization
Citations

This map shows the geographic impact of Barbara Scappini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Scappini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Scappini more than expected).

Fields of papers citing papers by Barbara Scappini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Scappini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Scappini. The network helps show where Barbara Scappini may publish in the future.

Co-authorship network of co-authors of Barbara Scappini

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Scappini. A scholar is included among the top collaborators of Barbara Scappini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Scappini. Barbara Scappini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bencini, Sara, Giacomo Gianfaldoni, Benedetta Peruzzi, et al.. (2023). APL-like Subset within NPM1-Mutated Acute Myeloid Leukemia: A Distinct Phenotypic Signature Correlating with Early-Onset Vascular Complications. Blood. 142(Supplement 1). 4224–4224. 1 indexed citations
2.
Pasquini, Andrea I., Francesco Mannelli, Barbara Scappini, et al.. (2023). ALL-256 Nelarabine, Etoposide, and Cyclophosphamide for Adult T Cell Acute Lymphoblastic Leukemia/lymphoma Relapsing After Pediatric-Inspired Frontline Approaches: Report of 3 Cases From a Real-Life Setting. Clinical Lymphoma Myeloma & Leukemia. 23. S242–S243. 1 indexed citations
3.
Iurlo, Alessandra, Massimo Breccia, Fabio Stagno, et al.. (2023). Full Treatment-Free Remission Outcome in Patients with Chronic Myeloid Leukemia in Chronic Phase Following One Year of Nilotinib De-Escalation: 96-Week Update of Dante Study. Blood. 142(Supplement 1). 4534–4534. 5 indexed citations
4.
Scappini, Barbara, Sara Bencini, Benedetta Peruzzi, et al.. (2021). Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience. Journal of Clinical Medicine. 10(8). 1684–1684. 23 indexed citations
5.
Mannelli, Francesco, Sara Bencini, Giacomo Gianfaldoni, et al.. (2020). Multilineage Dysplasia as Assessed by Immunophenotype in Acute Myeloid Leukemia: A Prognostic Tool in a Genetically Undefined Category. Cancers. 12(11). 3196–3196. 4 indexed citations
6.
Mannelli, Francesco, Giacomo Gianfaldoni, Sara Bencini, et al.. (2020). Early peripheral blast cell clearance predicts minimal residual disease status and refines disease prognosis in acute myeloid leukemia. American Journal of Hematology. 95(11). 1304–1313.
7.
Bartalucci, Niccolò, Francesco Mannelli, Elisa Contini, et al.. (2019). THIRD GENERATION SEQUENCING OF NORMAL KARYOTYPE ACUTE MYELOID LEUKEMIA: IMPLICATIONS FOR PROGNOSIS. Haematologica. 104. 12–12. 1 indexed citations
8.
Rigacci, Luigi, Umberto Restelli, Barbara Scappini, et al.. (2018). Lenograstim and filgrastim in the febrile neutropenia prophylaxis of hospitalized patients: efficacy and cost of the prophylaxis in a retrospective survey. Journal of Blood Medicine. Volume 10. 21–27. 4 indexed citations
9.
Bocchia, Monica, Sara Galimberti, Antonella Gozzini, et al.. (2014). ATHEROTHROMBOTIC RISK ASSESSMENT DURING TYROSINE KINASE INHIBITORS TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS: NEW INSIGHT?. Haematologica. 99. 533–534. 1 indexed citations
10.
Puccetti, Luca, Sara Galimberti, Antonella Gozzini, et al.. (2013). Atherothrombotic Risk and TKIs Treatment In Chronic Myeloid Leukemia Patients: A Role For Genetic Predisposition and Pro-Inflammatory/Pro-Oxidative Status?. Blood. 122(21). 1482–1482. 6 indexed citations
11.
Scappini, Barbara, Giacomo Gianfaldoni, F Caracciolo, et al.. (2012). Cytarabine and clofarabine after high‐dose cytarabine in relapsed or refractory AML patients. American Journal of Hematology. 87(12). 1047–1051. 21 indexed citations
12.
Oršolić, Nada, Mirna Golemović, Alfonso Quintás-Cardama, et al.. (2006). Adaphostin has significant and selective activity against chronic and acute myeloid leukemia cells. Cancer Science. 97(9). 952–960. 16 indexed citations
13.
Teodori, Elisabetta, et al.. (2005). Multidrug reverting activity toward leukemia cells in a group of new verapamil analogues with low cardiovascular activity. Leukemia Research. 30(1). 1–8. 18 indexed citations
14.
Scappini, Barbara, Francesco Onida, Clara Ricci, et al.. (2004). Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein. Cancer. 100(7). 1459–1471. 34 indexed citations
15.
Santini, Valeria, Barbara Scappini, Zena K. Indik, et al.. (2003). The carboxy-terminal region of the granulocyte colony-stimulating factor receptor transduces a phagocytic signal. Blood. 101(11). 4615–4622. 20 indexed citations
16.
Onida, Francesco, Greg Ball, Hagop M. Kantarjian, et al.. (2002). Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia. Cancer. 95(8). 1673–1684. 65 indexed citations
17.
Scappini, Barbara, Francesco Onida, Hagop M. Kantarjian, et al.. (2002). In vitro effects of STI 571‐containing drug combinations on the growth of Philadelphia‐positive chronic myelogenous leukemia cells. Cancer. 94(10). 2653–2662. 46 indexed citations
18.
Ricci, Clara, Barbara Scappini, Vladimír Divoký, et al.. (2002). Mutation in the ATP-binding pocket of the ABL kinase domain in an STI571-resistant BCR/ABL-positive cell line.. PubMed. 62(21). 5995–8. 65 indexed citations
19.
Scappini, Barbara, et al.. (2000). In vitro effects of STI571-containing drug combinations on growth of Ph-posittve myelogenous leukemia-derived cells. Blood. 96. 6 indexed citations
20.
Santini, Valeria, et al.. (1999). Maturation and apoptosis of primary human acute myeloblastic leukemia cells are determined by TNF-alpha exclusively through CD120A stimulation.. PubMed. 84(4). 291–7. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rafal Falinski Breakdown of academic impact, for papers by Roberta Rostagno Breakdown of academic impact, for papers by Christian Scharenberg Breakdown of academic impact, for papers by Cristina Panuzzo Breakdown of academic impact, for papers by Emanuela Messa Breakdown of academic impact, for papers by Ilaria Defilippi Breakdown of academic impact, for papers by Giovanna Rege Cambrin Breakdown of academic impact, for papers by Amity Frede Breakdown of academic impact, for papers by Victoria Raggueneau Breakdown of academic impact, for papers by Florian Perner
Rankless by CCL
2026